BioMed Research International / 2017 / Article / Fig 1

Research Article

Biocompatibility and Effectiveness Evaluation of a New Hemostatic Embolization Agent: Thrombin Loaded Alginate Calcium Microsphere

Figure 1

The establishment of hepatic injured and hemorrhagic models of beagles and the interventional embolization using TACMs mixed thrombus. (a) The angiography of the normal hepatic artery; (b) the hemorrhage model made by a Swartz sheath (blue arrow); (c) the continuous leakage of contrast agent from injured right hepatic artery 5 minutes after hemorrhage model was established (red arrow); (d) the delivery of TACMs mixed thrombus (white arrow) by guiding catheter; (e) bleeding stopped completely after embolization; (f) angiography 1 week later after embolization; (g) angiography 4 weeks later after embolization; (h) angiography 12 weeks later after embolization.
(a)
(b)
(c)
(d)
(e)
(f)
(g)
(h)

Article of the Year Award: Outstanding research contributions of 2020, as selected by our Chief Editors. Read the winning articles.